Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Will a New Model Secure Science Research Funding?
Management & Administration Will a New Model Secure Science Research Funding?

The intricate web of scientific discovery, which yields life-saving medical treatments and technological marvels, relies on a financial backbone that often goes unnoticed by the public. Beyond the direct costs of researchers and lab equipment lies a vast array of essential operational expenses,

Review of Humana Agent Assist
Tech & Innovation Review of Humana Agent Assist

The monumental challenge of delivering consistent, empathetic support across millions of annual customer interactions has long been a significant hurdle for the healthcare industry. Humana's Agent Assist, a sophisticated AI tool developed with Google Cloud, enters this landscape not as a

Can Care Pathways Redefine Rehab Performance?
Management & Administration Can Care Pathways Redefine Rehab Performance?

The American healthcare landscape is undergoing a profound and irreversible transformation, moving decisively away from a volume-based, fee-for-service model toward a value-based care system that prioritizes quality outcomes and cost-efficiency. For the community of rehabilitation

Who Was the Pioneer of Digital Health Records?
Tech & Innovation Who Was the Pioneer of Digital Health Records?

The seamless access to patient data that modern healthcare professionals now take for granted was once a distant dream, a concept forged in an era of cumbersome paper files and handwritten charts. The recent passing of A. Neil Pappalardo on January 27 at the age of 83 marks the end of an era for

Hernando Schools Weigh New Health Plan to Cut Costs
Management & Administration Hernando Schools Weigh New Health Plan to Cut Costs

Faced with the staggering reality of a $21 million annual expenditure on employee health insurance, the Hernando County School Board has initiated a decisive step toward potentially overhauling its entire benefits program. In a recent meeting, the board voted unanimously to authorize a

Can This Team Fix Healthcare's Data Crisis?
Tech & Innovation Can This Team Fix Healthcare's Data Crisis?

A significant shift in the European technology landscape is underway, marked by the return of top-tier talent from competitive American tech hubs to tackle some of the continent's most entrenched problems. Berlin-based health-tech firm aiomics is at the forefront of this movement, recently

HIV Pioneer Myron Cohen to Step Down as IGHID Director
Clinical & Pharma HIV Pioneer Myron Cohen to Step Down as IGHID Director

A monumental shift in leadership is set for this June, as Dr. Myron (Mike) Cohen, a towering figure in infectious disease research and the founding director of the Institute for Global Health and Infectious Diseases (IGHID), has announced he will be stepping down from his role. This transition

Can Operator VCs Fix A Broken Healthcare System?
Tech & Innovation Can Operator VCs Fix A Broken Healthcare System?

The Rise of the Operator VC: A New Prescription for an Ailing Industry? The American healthcare system is a study in contradictions—a world of breathtaking innovation plagued by systemic inefficiency, skyrocketing costs, and widespread frustration. For years, venture capital has poured billions

Medicare Rate Proposal Sparks Health Insurer Sell-Off
Management & Administration Medicare Rate Proposal Sparks Health Insurer Sell-Off

A shockwave tore through the managed-care sector as a U.S. government proposal for 2027 Medicare Advantage payment rates ignited a firestorm of investor concern, leading to a significant sell-off of health insurer stocks. The tremors were felt most acutely at UnitedHealth Group, which saw its

Is US Policy Ignoring Long COVID's Lasting Harm?
Clinical & Pharma Is US Policy Ignoring Long COVID's Lasting Harm?

With the official end of the COVID-19 pandemic declared over a year ago, many are moving on. Yet, a steady stream of research reveals a more complicated and concerning picture of the virus's long-term impact on our bodies and brains. To unpack these findings and what they mean for public health,

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later